by Randy A. Sansone, MD, and Lori A. Sansone, MD

Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. L. Sansone is a family medicine physician (government service) and Medical Director of the Primary Care Clinic at Wright-Patterson Air Force Base. The views and opinions expressed in this column are those of the authors and do not reflect the official policy or the position of the United States Air Force, Department of Defense, or US government.

Popularity: unranked [?]

Related posts

• Treatment of Schizoaffective Disorder
• Generic Penetration in the Retail Antidepressant Market
• Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study
• Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysphoric Disorder
• Use of Benzodiazepines in the Treatment of Anxiety
• Warfarin and Antidepressants: Happiness without Hemorrhaging
• Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning
• Real-World Data on SSRI Antidepressant Side Effects
• Letters to the Editor